Literature DB >> 21835380

Myocardial perfusion imaging is a strong predictor of death in women.

Mario Sergio Julio Cerci1, Juliano Julio Cerci, Rodrigo Julio Cerci, Carlos Cunha Pereira Neto, Evelinda Trindade, Dominique Delbeke, Claudio L Pereira da Cunha, João Vicente Vitola.   

Abstract

OBJECTIVES: We sought to assess the prognostic value and risk classification improvement using contemporary single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) to predict all-cause mortality.
BACKGROUND: Myocardial perfusion is a strong estimator of prognosis. Evidence published to date has not established the added prognostic value of SPECT-MPI nor defined an approach to detect improve classification of risk in women from a developing nation.
METHODS: A total of 2,225 women referred for SPECT-MPI were followed by a mean period of 3.7 ± 1.4 years. SPECT-MPI results were classified as abnormal on the presence of any perfusion defect. Abnormal scans were further classified as with mild/moderate reversible, severe reversible, partial reversible, or fixed perfusion defects. Risk estimates for incident mortality were categorized as <1%/year, 1% to 2%/year, and >2%/year using Cox proportional hazard models. Risk-adjusted models incorporated clinical risk factors, left ventricular ejection fraction (LVEF), and perfusion variables.
RESULTS: All-cause death occurred in 139 patients. SPECT-MPI significantly risk stratified the population; patients with abnormal scans had significantly higher death rates compared with patients with normal scans, 13.1% versus 4.0%, respectively (p < 0.001). Cox analysis demonstrated that after adjusting for clinical risk factors and LVEF, SPECT-MPI improved the model discrimination (integrated discrimination index = 0.009; p = 0.02), added significant incremental prognostic information (global chi-square increased from 87.7 to 127.1; p < 0.0001), and improved risk prediction (net reclassification improvement = 0.12; p = 0.005).
CONCLUSIONS: SPECT-MPI added significant incremental prognostic information to clinical and left ventricular functional variables while enhancing the ability to classify this Brazilian female population into low- and high-risk categories of all-cause mortality.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21835380     DOI: 10.1016/j.jcmg.2011.06.009

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  17 in total

Review 1.  Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease.

Authors:  Lauren A Baldassarre; Subha V Raman; James K Min; Jennifer H Mieres; Martha Gulati; Nanette K Wenger; Thomas H Marwick; Chiara Bucciarelli-Ducci; C Noel Bairey Merz; Dipti Itchhaporia; Keith C Ferdinand; Carl J Pepine; Mary Norine Walsh; Jagat Narula; Leslee J Shaw
Journal:  JACC Cardiovasc Imaging       Date:  2016-04

2.  Outcome of patients with high-risk Duke treadmill score and normal myocardial perfusion imaging on spect.

Authors:  João V Vítola; Mauro R B Wanderley; Rodrigo J Cerci; Carlos C Pereira Neto; Otávio Kormann; Olímpio França Neto; José Antônio da Silva; Cláudio L Pereira da Cunha; Isabella Shin-Ike; Arnaldo L Stier
Journal:  J Nucl Cardiol       Date:  2015-06-03       Impact factor: 5.952

Review 3.  Utility of Imaging in Risk Stratification of Chest Pain in Women.

Authors:  Emily S Lau; Amy Sarma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09

4.  High-sensitivity troponin T and C-reactive protein to identify patients without cardiac structural and functional abnormalities as assessed by cardiac CT and SPECT imaging: can biomarkers predict cardiac health?

Authors:  Christopher L Schlett; Quynh A Truong; Waleed Ahmed; Ron Blankstein; Maros Ferencik; Shanmugam Uthamalingam; Fabian Bamberg; Wolfgang Koenig; James L Januzzi; Udo Hoffmann
Journal:  Int J Cardiovasc Imaging       Date:  2013-01-01       Impact factor: 2.357

Review 5.  The role of imaging in women with ischemic heart disease.

Authors:  Niti R Aggarwal; Rachel M Bond; Jennifer H Mieres
Journal:  Clin Cardiol       Date:  2018-03-05       Impact factor: 2.882

6.  Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.

Authors:  Viviany R Taqueti; Sharmila Dorbala; David Wolinsky; Brian Abbott; Gary V Heller; Timothy M Bateman; Jennifer H Mieres; Lawrence M Phillips; Nanette K Wenger; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2017-06-05       Impact factor: 5.952

Review 7.  Assessing clinical impact of myocardial perfusion studies: ischemia or other prognostic indicators?

Authors:  Todd D Miller; John Wells Askew; Joerg Herrmann
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

8.  Prognosis in patients with suspected or known ischemic heart disease and normal myocardial perfusion: long-term outcome and temporal risk variations.

Authors:  Jane A Simonsen; Oke Gerke; Charlotte K Rask; Mohammad Tamadoni; Anders Thomassen; Søren Hess; Allan Johansen; Hans Mickley; Lisette O Jensen; Jesper Hallas; Werner Vach; Poul F Høilund-Carlsen
Journal:  J Nucl Cardiol       Date:  2013-03-01       Impact factor: 5.952

9.  Evaluating gender differences in prognosis following SPECT myocardial perfusion imaging among patients with diabetes and known or suspected coronary disease in the modern era.

Authors:  Maria Theresa H Santos; Matthew W Parker; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-08-21       Impact factor: 5.952

10.  Appropriate use criteria for SPECT myocardial perfusion imaging: Are they appropriate for women?

Authors:  Rami Doukky; Kathleen Hayes; Nathan Frogge
Journal:  J Nucl Cardiol       Date:  2015-08-25       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.